Verseon has assembled a talented team of scientists, engineers and business development professionals to bring its breakthrough drug discovery technology to the market. Team members have an unmatched set of skills ranging from expertise in proteomics and molecular modeling, medicinal chemistry, biochemical synthesis and screening, to the design and implementation of complex mathematical algorithms. Senior team members are: 

Adityo Prakash, Founder, CEO : Experienced in bringing breakthrough technologies to market; co-founded Pulsent Corp.; inventor on over 40 pending and/or issued patents; BS, Caltech

Eniko Fodor, Founder, COO : Experienced in building cutting edge technology organizations with highly effective operating, marketing & IP strategy; co-founded Pulsent Corp.; inventor on over 25 pending and/or issued patents: BS, Universitatea Babes Bolyai, Romania 

David Kita, Founder, VP R&D : Experienced in leading large algorithm development teams through successful new product introductions in bioinformatics and signal processing; was Dir R&D at Pulsent Corp. and Dir. Bioinformatics at Hyseq Pharmaceuticals; inventor on over 20 pending and/or issued patents, Ph.D., Univ. of Wisconsin, Madison

Kevin Short, Director Discovery Programs : Experienced in drug discovery planning, program evaluation and business development; led successful drug discovery programs from inception to the clinic; was Principal Scientist at J&J and Ontogen Corporation; inventor on over 12 drug patents, Ph.D., Univ. of Exeter, UK